Annual Revenue
$20.00 K
-$406.00 K-95.31%
December 31, 2024
Summary
- As of March 5, 2025, ALT annual revenue is $20.00 thousand, with the most recent change of -$406.00 thousand (-95.31%) on December 31, 2024.
- During the last 3 years, ALT annual revenue has fallen by -$4.39 million (-99.55%).
- ALT annual revenue is now -99.94% below its all-time high of $32.91 million, reached on December 31, 2008.
Performance
ALT Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
$5000.00
$0.000.00%
December 31, 2024
Summary
- As of March 5, 2025, ALT quarterly revenue is $5000.00, unchanged on December 31, 2024.
- Over the past year, ALT quarterly revenue has dropped by -$32.00 thousand (-86.49%).
- ALT quarterly revenue is now -99.95% below its all-time high of $10.91 million, reached on June 30, 2008.
Performance
ALT Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM Revenue
$20.00 K
-$32.00 K-61.54%
December 31, 2024
Summary
- As of March 5, 2025, ALT TTM revenue is $20.00 thousand, with the most recent change of -$32.00 thousand (-61.54%) on December 31, 2024.
- Over the past year, ALT TTM revenue has dropped by -$406.00 thousand (-95.31%).
- ALT TTM revenue is now -99.94% below its all-time high of $33.39 million, reached on September 30, 2008.
Performance
ALT TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ALT Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -95.3% | -86.5% | -95.3% |
| 3 y3 years | -99.5% | -99.8% | -99.5% |
| 5 y5 years | -99.7% | -99.1% | -99.7% |
ALT Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.5% | +129.4% | -99.8% | +104.5% | -99.5% | +124.7% |
| 5 y | 5-year | -99.8% | +129.4% | -99.8% | +104.5% | -99.8% | +124.7% |
| alltime | all time | -99.9% | +129.4% | -100.0% | +104.5% | -99.9% | +124.7% |
Altimmune Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $20.00 K(-95.3%) | $5000.00(0.0%) | $20.00 K(-61.5%) |
| Sep 2024 | - | $5000.00(0.0%) | $52.00 K(-87.3%) |
| Jun 2024 | - | $5000.00(0.0%) | $409.00 K(-0.2%) |
| Mar 2024 | - | $5000.00(-86.5%) | $410.00 K(-3.8%) |
| Dec 2023 | $426.00 K(-726.5%) | $37.00 K(-89.8%) | $426.00 K(+52.7%) |
| Sep 2023 | - | $362.00 K(+5933.3%) | $279.00 K(-444.4%) |
| Jun 2023 | - | $6000.00(-71.4%) | -$81.00 K(+2.5%) |
| Mar 2023 | - | $21.00 K(-119.1%) | -$79.00 K(+16.2%) |
| Dec 2022 | -$68.00 K(-101.5%) | -$110.00 K(-5600.0%) | -$68.00 K(-102.0%) |
| Sep 2022 | - | $2000.00(-75.0%) | $3.32 M(-4.5%) |
| Jun 2022 | - | $8000.00(-75.0%) | $3.48 M(-3.6%) |
| Mar 2022 | - | $32.00 K(-99.0%) | $3.60 M(-18.3%) |
| Dec 2021 | $4.41 M(-46.1%) | $3.28 M(+1974.1%) | $4.41 M(+28.0%) |
| Sep 2021 | - | $158.00 K(+15.3%) | $3.45 M(-44.7%) |
| Jun 2021 | - | $137.00 K(-83.7%) | $6.23 M(-8.6%) |
| Mar 2021 | - | $838.00 K(-63.8%) | $6.81 M(-16.8%) |
| Dec 2020 | $8.19 M(+41.1%) | $2.31 M(-21.3%) | $8.19 M(+26.9%) |
| Sep 2020 | - | $2.94 M(+307.2%) | $6.45 M(+55.2%) |
| Jun 2020 | - | $721.60 K(-67.4%) | $4.15 M(-17.9%) |
| Mar 2020 | - | $2.21 M(+284.3%) | $5.06 M(-12.8%) |
| Dec 2019 | $5.80 M(-43.8%) | $575.80 K(-10.6%) | $5.80 M(-25.8%) |
| Sep 2019 | - | $644.00 K(-60.4%) | $7.81 M(-20.3%) |
| Jun 2019 | - | $1.63 M(-45.0%) | $9.80 M(-7.5%) |
| Mar 2019 | - | $2.96 M(+14.2%) | $10.60 M(+2.6%) |
| Dec 2018 | $10.33 M(-3.8%) | $2.59 M(-1.7%) | $10.33 M(-44.0%) |
| Sep 2018 | - | $2.63 M(+9.0%) | $18.44 M(+16.5%) |
| Jun 2018 | - | $2.42 M(-10.2%) | $15.84 M(+18.0%) |
| Mar 2018 | - | $2.69 M(-74.9%) | $13.42 M(+25.0%) |
| Dec 2017 | $10.74 M(+2518.5%) | $10.70 M(>+9900.0%) | $10.74 M(+3758.5%) |
| Sep 2017 | - | $26.70 K(+444.9%) | $278.30 K(+8.5%) |
| Jun 2017 | - | $4900.00(0.0%) | $256.50 K(-37.5%) |
| Mar 2017 | - | $4900.00(-98.0%) | $410.10 K(-70.9%) |
| Dec 2016 | $410.10 K(-96.1%) | $241.80 K(+4834.7%) | $1.41 M(-42.1%) |
| Sep 2016 | - | $4900.00(-96.9%) | $2.44 M(-32.1%) |
| Jun 2016 | - | $158.50 K(-84.2%) | $3.59 M(-21.7%) |
| Mar 2016 | - | $1.01 M(-20.6%) | $4.58 M(-57.0%) |
| Dec 2015 | $10.64 M | $1.27 M(+9.6%) | $10.64 M(-5.0%) |
| Sep 2015 | - | $1.16 M(+0.5%) | $11.20 M(+1.8%) |
| Jun 2015 | - | $1.15 M(-83.7%) | $11.01 M(-18.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $7.07 M(+287.1%) | $13.52 M(+32.6%) |
| Dec 2014 | $10.19 M(-43.1%) | $1.83 M(+89.7%) | $10.19 M(-15.2%) |
| Sep 2014 | - | $962.50 K(-73.7%) | $12.02 M(-17.4%) |
| Jun 2014 | - | $3.66 M(-2.2%) | $14.54 M(-4.2%) |
| Mar 2014 | - | $3.74 M(+2.4%) | $15.18 M(-15.3%) |
| Dec 2013 | $17.91 M(-28.9%) | $3.65 M(+4.8%) | $17.91 M(-11.6%) |
| Sep 2013 | - | $3.49 M(-18.8%) | $20.27 M(-13.7%) |
| Jun 2013 | - | $4.30 M(-33.7%) | $23.48 M(-7.9%) |
| Mar 2013 | - | $6.48 M(+7.7%) | $25.50 M(+1.3%) |
| Dec 2012 | $25.18 M(+3.7%) | $6.01 M(-10.2%) | $25.18 M(-0.9%) |
| Sep 2012 | - | $6.70 M(+6.0%) | $25.40 M(+6.0%) |
| Jun 2012 | - | $6.32 M(+2.7%) | $23.97 M(-0.5%) |
| Mar 2012 | - | $6.15 M(-1.5%) | $24.08 M(-0.8%) |
| Dec 2011 | $24.27 M(+15.6%) | $6.24 M(+18.6%) | $24.27 M(-2.5%) |
| Sep 2011 | - | $5.26 M(-18.2%) | $24.88 M(-3.8%) |
| Jun 2011 | - | $6.43 M(+1.4%) | $25.86 M(+6.8%) |
| Mar 2011 | - | $6.34 M(-7.5%) | $24.21 M(+15.3%) |
| Dec 2010 | $20.99 M(-23.8%) | $6.85 M(+9.8%) | $20.99 M(-1.3%) |
| Sep 2010 | - | $6.24 M(+30.6%) | $21.27 M(-2.7%) |
| Jun 2010 | - | $4.78 M(+53.4%) | $21.85 M(-13.1%) |
| Mar 2010 | - | $3.12 M(-56.3%) | $25.14 M(-8.7%) |
| Dec 2009 | $27.55 M(-16.3%) | $7.13 M(+4.3%) | $27.55 M(+6.4%) |
| Sep 2009 | - | $6.83 M(-15.4%) | $25.90 M(-12.9%) |
| Jun 2009 | - | $8.07 M(+46.2%) | $29.75 M(-8.7%) |
| Mar 2009 | - | $5.52 M(+0.8%) | $32.59 M(-1.0%) |
| Dec 2008 | $32.91 M(+124.7%) | $5.48 M(-48.7%) | $32.91 M(-1.4%) |
| Sep 2008 | - | $10.68 M(-2.2%) | $33.39 M(+28.0%) |
| Jun 2008 | - | $10.91 M(+86.9%) | $26.09 M(+49.7%) |
| Mar 2008 | - | $5.84 M(-2.1%) | $17.42 M(+19.7%) |
| Dec 2007 | $14.64 M(+780.4%) | $5.96 M(+76.8%) | $14.55 M(+44.6%) |
| Sep 2007 | - | $3.37 M(+50.0%) | $10.06 M(+50.4%) |
| Jun 2007 | - | $2.25 M(-24.3%) | $6.69 M(+36.3%) |
| Mar 2007 | - | $2.97 M(+101.2%) | $4.91 M(+109.2%) |
| Dec 2006 | $1.66 M(+183.8%) | $1.48 M(>+9900.0%) | $2.35 M(+87.5%) |
| Sep 2006 | - | $1600.00(-99.7%) | $1.25 M(-14.0%) |
| Jun 2006 | - | $466.00 K(+15.1%) | $1.46 M(+47.0%) |
| Mar 2006 | - | $405.00 K(+6.6%) | $991.10 K(+69.1%) |
| Dec 2005 | $586.10 K | $379.80 K(+84.1%) | $586.10 K(+184.1%) |
| Sep 2005 | - | $206.30 K | $206.30 K |
FAQ
- What is Altimmune annual revenue?
- What is the all time high annual revenue for Altimmune?
- What is Altimmune annual revenue year-on-year change?
- What is Altimmune quarterly revenue?
- What is the all time high quarterly revenue for Altimmune?
- What is Altimmune quarterly revenue year-on-year change?
- What is Altimmune TTM revenue?
- What is the all time high TTM revenue for Altimmune?
- What is Altimmune TTM revenue year-on-year change?
What is Altimmune annual revenue?
The current annual revenue of ALT is $20.00 K
What is the all time high annual revenue for Altimmune?
Altimmune all-time high annual revenue is $32.91 M
What is Altimmune annual revenue year-on-year change?
Over the past year, ALT annual revenue has changed by -$406.00 K (-95.31%)
What is Altimmune quarterly revenue?
The current quarterly revenue of ALT is $5000.00
What is the all time high quarterly revenue for Altimmune?
Altimmune all-time high quarterly revenue is $10.91 M
What is Altimmune quarterly revenue year-on-year change?
Over the past year, ALT quarterly revenue has changed by -$32.00 K (-86.49%)
What is Altimmune TTM revenue?
The current TTM revenue of ALT is $20.00 K
What is the all time high TTM revenue for Altimmune?
Altimmune all-time high TTM revenue is $33.39 M
What is Altimmune TTM revenue year-on-year change?
Over the past year, ALT TTM revenue has changed by -$406.00 K (-95.31%)